Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system
Article in Frontiers in Pharmacology (June 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (June 2024)
Article in Expert Opinion on Drug Safety (May 2024)
Article in Frontiers in Medicine (April 2024)